unknown
Stage
1
Investors
About
Operator of a biopharmaceutical company intended to create targeted biogenic drug delivery systems for biotherapeutics. The company offers bespoke services for biotherapeutic drug delivery, enabling customers to develop programmable, modular living therapies.
Explore Hijack Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.